|
PMID
|
Match String
|
Actual String
|
Score
|
Flanking text
|
Edited by
|
Edit
|
| 16104843 | PI3K | PI3K | 1.0 | for endothelial cells from VEGFR-2 is reported to involve the PI3K (phosphoinositide phosphoinositide 3-kinase)/Akt 3-kinase Akt pathway 82 83 ( Figure | |  |
| 16104843 | PI3K | PI3K | 1.0 | another pathway may be involved since the signal to activate PI3K by VEGFR-2 is usually not very strong | |  |
| 16104843 | PI3K | PI3K | 1.0 | the activation of VEGFR-2 by VEGF-A results in the PI3K/Akt-dependent PI3K Akt-dependent activation of several integrins leading to enhanced cell adhesion | |  |
| 16104843 | PI3K | PI3K-dependent | 1.0 | phosphorylation of VEGFR-3 has been shown to lead to a PI3K-dependent activation of Akt and PKC (protein protein kinase C -dependent | |  |
| 16104843 | PI3K | PI3K | 1.0 | The activation of the PI3K/p70 PI3K p70 S6K (S6 S6 kinase pathway by VEGFR-2 is also | |  |
| 16104843 | PI3K | PI3K | 1.0 | Furthermore the activation of eNOS is regulated by the PI3K/Akt PI3K Akt pathway 123 124 | |  |
| 16104843 | PI3K | PI3K | 1.0 | The small GTP-binding protein Rac which is also activated by PI3K has been implicated in the regulation of vascular permeability 125 | |  |
| 16104843 | PI3K | PI3K | 1.0 | neuropilin PAIP2 polyadenylated-binding protein-interacting protein 2 PDK1 phosphoinositide-dependent kinase 1 PI3K phosphoinositide 3-kinase PILSAP puromycin-intensive leucyl-specific aminopeptidase PKC protein kinase C | |  |
| 16647138 | PI3 | PI3-kinase | 0.3 | upregulates both endothelial nitric oxide synthase (eNOS) eNOS and PI3-kinase/Akt PI3-kinase Akt pathways | Junguk Hur |  |
| 16647138 | PI3 | PI3-kinase | 0.3 | Not only eNOS inhibitors but also PI3-kinase/Akt PI3-kinase Akt signaling pathway inhibitors can prevent this upregulation by EPOX | Junguk Hur |  |
| 16647138 | PI3 | PI3-kinase | 0.3 | This indicates that both eNOS and PI3-kinase/Akt PI3-kinase Akt pathways may mediate the angiogenic effects of EETs ( | Junguk Hur |  |
| 16647138 | PI3 | PI3-kinase | 0.3 | via a nitric-oxide-dependent mechanism as well as via activation of PI3-kinase and MARK pathways ( Wang et al. 2003 and Wang | Junguk Hur |  |
| 16624536 | phosphatidylinositol 3-kinase | phosphatidylinositol 3 kinase | 1.0 | through activation of the phosphatidylinositol 3 kinase/protein kinase b pathway fractalkine will inhibit fas ligand induced microglial apoptosis through down regulation of the pro apoptotic function of bad and up regulation of the anti apoptotic activity | |  |
| 16647138 | pi3-kinase | pi3 kinase | 1.0 | in endothelial cell cultures the overexpression of epox upregulates both endothelial nitric oxide synthase enos and pi3 kinase/akt pathways. | Junguk Hur |  |
| 16647138 | pi3-kinase | pi3 kinase | 1.0 | not only enos inhibitors but also pi3 kinase/akt signaling pathway inhibitors can prevent this upregulation by epox. | Junguk Hur |  |
| 16647138 | pi3-kinase | pi3 kinase | 1.0 | this indicates that both enos and pi3 kinase/akt pathways may mediate the angiogenic effects of eets kawasaki et al. 2003 . | Junguk Hur |  |
| 16647138 | pi3-kinase | pi3 kinase | 1.0 | collectively these studies suggest that epox derived eets modulate angiogenesis via a nitric oxide dependent mechanism as well as via activation of pi3 kinase and mark pathways wang et al. 2003 and wang et al. 2005b . | Junguk Hur |  |
| 16647138 | phosphatidylinositol 3-kinase | phosphatidylinositol 3 kinase | 1.0 | paf stimulates phosphatidylinositol 3 kinase and mitogen activated protein map kinase and inhibits adenylate cyclase. | |  |
| 16753239 | phosphatidylinositol 3-kinase | phosphatidylinositol 3 kinase | 1.0 | furthermore the studies demonstrated that 15d pgj 2 also altered astrocyte expression of these pro inflammatory molecules by inhibiting the phosphatidylinositol 3 kinase akt signaling pathway. | |  |
| 17350694 | phosphatidylinositol 3-kinase | phosphatidylinositol 3 kinase | 1.0 | cascades; iii antioxidant activity mainly owing to the phenol group of various resorcinol type cannabinoids; iv suppression of the production of tumor necrosis factor _amp_#x3b1;; v activation of the phosphatidylinositol 3 kinase and protein kinase b pathway; vi induction of phosphorylation of extracellular regulated kinases; and vii induction of the expression of transcription factors and neurotrophins. | |  |